Osman I - Search Results

1

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).

Ferguson R, Archambault A, Simpson D, Morales L, Chat V, Kazlow E, Lax R, Yoon G, Moran U, Shapiro R, Pavlick A, Polsky D, Osman I, Kirchhoff T. Ferguson R, et al. Among authors: osman i. Sci Rep. 2019 Jul 15;9(1):10173. doi: 10.1038/s41598-019-46665-z. Sci Rep. 2019. PMID: 31308438 Free PMC article.

2

HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.

Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C, Osman I. Polsky D, et al. Among authors: osman i. Cancer Res. 2001 Oct 15;61(20):7642-6. Cancer Res. 2001. PMID: 11606406

3

Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.

Hazan C, Melzer K, Panageas KS, Li E, Kamino H, Kopf A, Cordon-Cardo C, Osman I, Polsky D. Hazan C, et al. Among authors: osman i. Cancer. 2002 Aug 1;95(3):634-40. doi: 10.1002/cncr.10685. Cancer. 2002. PMID: 12209757 Free article.

4

HDM2 protein overexpression and prognosis in primary malignant melanoma.

Polsky D, Melzer K, Hazan C, Panageas KS, Busam K, Drobnjak M, Kamino H, Spira JG, Kopf AW, Houghton A, Cordon-Cardo C, Osman I. Polsky D, et al. Among authors: osman i. J Natl Cancer Inst. 2002 Dec 4;94(23):1803-6. doi: 10.1093/jnci/94.23.1803. J Natl Cancer Inst. 2002. PMID: 12464652

5

Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.

Gorden A, Osman I, Gai W, He D, Huang W, Davidson A, Houghton AN, Busam K, Polsky D. Gorden A, et al. Among authors: osman i. Cancer Res. 2003 Jul 15;63(14):3955-7. Cancer Res. 2003. PMID: 12873990

6

Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.

Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D. Abbasi NR, et al. Among authors: osman i. JAMA. 2004 Dec 8;292(22):2771-6. doi: 10.1001/jama.292.22.2771. JAMA. 2004. PMID: 15585738 Review.

7

Clinical significance of BRAF mutations in metastatic melanoma.

Chang DZ, Panageas KS, Osman I, Polsky D, Busam K, Chapman PB. Chang DZ, et al. Among authors: osman i. J Transl Med. 2004 Dec 21;2(1):46. doi: 10.1186/1479-5876-2-46. J Transl Med. 2004. PMID: 15613230 Free PMC article.

8

Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry.

Hale EK, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, Osman I, Kopf AW, Polsky D. Hale EK, et al. Among authors: osman i. Br J Dermatol. 2005 Mar;152(3):512-7. doi: 10.1111/j.1365-2133.2005.06316.x. Br J Dermatol. 2005. PMID: 15787820

9

PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.

Mikhail M, Velazquez E, Shapiro R, Berman R, Pavlick A, Sorhaindo L, Spira J, Mir C, Panageas KS, Polsky D, Osman I. Mikhail M, et al. Among authors: osman i. Clin Cancer Res. 2005 Jul 15;11(14):5153-7. doi: 10.1158/1078-0432.CCR-05-0397. Clin Cancer Res. 2005. PMID: 16033830

10

Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.

Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, O'Neill D, Yu YL, Spira J, Christos PJ, Zhou XK, Mazumdar M, Nanus DM, Liebes L, Bhardwaj N, Polsky D, Osman I. Velazquez EF, et al. Among authors: osman i. J Transl Med. 2007 Jan 5;5:2. doi: 10.1186/1479-5876-5-2. J Transl Med. 2007. PMID: 17207277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters